{{Rsnum
|rsid=7872515
|Gene=SPTLC1
|Chromosome=9
|position=92060258
|Orientation=plus
|GMAF=0.2971
|Gene_s=SPTLC1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 2.7 | 19.5 | 77.9
| HCB | 6.6 | 42.3 | 51.1
| JPT | 8.0 | 41.6 | 50.4
| YRI | 37.4 | 47.6 | 15.0
| ASW | 22.8 | 54.4 | 22.8
| CHB | 6.6 | 42.3 | 51.1
| CHD | 11.9 | 50.5 | 37.6
| GIH | 0.0 | 23.8 | 76.2
| LWK | 24.5 | 46.4 | 29.1
| MEX | 13.8 | 43.1 | 43.1
| MKK | 14.7 | 51.9 | 33.3
| TSI | 2.9 | 16.7 | 80.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22688191
|Trait=None
|Title=Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
|RiskAllele=
|Pval=6E-7
|OR=1.3900
|ORtxt=None
|OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}